FCGR2A and cancer: Conversely, overexpression of HLA-DRB1, CXCR3, CCL4, ISG15, FCGR2A, FCGR3A, SELL, and CCR5 was associated with a significantly higher survival rate, revealing their vital role in inhibiting the progression of cancer.